🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Dodge your inaugural lecture for years, then open with tennis coach shout-outs and tequila stories with PhD virologist rock stars. Read more about #HIV researcher Francois Venter’s journey in this week’s newsletter. mailchi.mp/bhekisisa.org/…

📰 Just launched! New Journal of the IAS supplement highlights the importance of expanding access to different #PrEP choices for the future of #HIV prevention. Wits RHI FHI 360 bit.ly/JIASPrEP

On this #zerohivstigmaday, we launch the Global AIDS Update Report highlighting progress made&challenges that persist in ending AIDS by 2030. We remember iconic Prudence Mabele who bravely fought against stigma&discrimination which today remains a barrier to healthcare.

Join our next webinar: Nurses face rising strain from funding cuts & service gaps in HIV care. Let’s talk mental health & why supporting nurses is vital for HIV services. Tonight: bit.ly/3IeyXji 15 July: bit.ly/4nysWOw #HIVCare #SupportNurses Spotlight

We are excited to be attending the IAS conference, and look forward to sharing highlights with you over the coming days! #IAS2025

#IAS2025 updates: Re-imagining prevention: Planning for sustainable PrEP access in a new funding context. This graph is a sobering reminder of the potential disruptions caused by reduced access to #PrEP, as presented by Mitchell Warren AVAC

#IAS2025 updates: Re-imagining prevention: Planning for sustainable PrEP access in a new funding context. The prevention landscape has the potential to be further transformed in the next three years. With innovation in products comes the need for innovation in service delivery

Please see the new WHO guidelines on #lenacapavir for #PrEP here sahivsoc.org/Files/97892401… as well as the recently published Southern African HIV Clinicians Society PrEP guidelines sahivsoc.org/Files/SAHCS%20…, which align with the WHO’s newly launched guidelines

💉 SA has accepted $29M from the Global Fund to buy a 2-times-a-year jab that could help end #Aids. But there’s a catch, our Mia Malan reports: the money isn’t extra. #Lenacapavir #IAS2025 bhekisisa.org/health-news-so…

#IAS2025 Systematic review and meta-analysis of the efficacy of intermittent antiretroviral therapy dosing: a crisis response to the sudden cuts in funding - Presented by Cassandra Fairhead. You can hear more on this at the upcoming SAHCS Conference sahcsconference.co.za

Scientists say #lenacapavir could stop new #HIV infections completely in young women. Now SA has funding to start … but @healthza and activists say price secrecy is a problem. #PrEP #HealthJustice #IAS2025 bhekisisa.org/health-news-so…

Congratulations to the new recipients of the latest CIPHER Grants, announced at the #IAS2025 conference To all paediatric & adolescent #HIV researchers don’t miss your chance to make an impact. Keep an eye out for the next CIPHER grant cycle opening 1 September 2025 and apply!

MUST READ | South Africa is staging a sequel to Mbeki-era denialism, only this time, the science, solutions, and costs are clearer, argues Professor Francois Venter. spotlightnsp.co.za/2025/07/16/fra…

Starting now ⤵️ Lessons from Lesotho's comprehensive Advanced HIV Disease program. Supported by CHAI and the Ministry of Health, the program used a hub-and-spoke model to expand national AHD services from 7% in 2021 to 100% coverage by 2024. 🎉 #IAS2025

Asking the relevant questions is a central piece to any meaningful strategy IAS - the International AIDS Society

#IAS2025 update: New evidence on cervical cancer in women living with HIV (WLWH). Kathy Anastos & Gad Murenzi highlight the heightened burden & call for HPV vaccination as key prevention. See WHO’s global strategy: lnkd.in/dmhefEr2 #CervicalCancer #HPV #WLWH #HIVCare

#IAS2025 update: 96-week results from BREATHER Plus show weekend-off ART is inferior to continuous ART in adolescents on TLD in sub-Saharan Africa. Presented by Adeodata Kekitiinwa. More: lnkd.in/dmMns6M4 #HIVResearch #Adolescents #HIVTreatment

Dr. Jirair Ratevosian Linda-Gail Bekker #IAS2025: Find out more on what the U.S Senate vote to protect #PEPFAR funds means for the HIV response here: health-e.org.za/2025/07/17/u-s… via Inappropriate IAS - the International AIDS Society Linda-Gail Bekker Dr. Jirair Ratevosian

#IAS2025 48-week results from the IMPALA trial: a phase 3 study testing 2-monthly injectable cabotegravir + rilpivirine LA vs daily oral ART in people with sub-optimal HIV control in sub-Saharan Africa.

AHF was honored to exhibit alongside researchers and experts from around the world at #IAS2025 . This global collaboration inspires us to keep advancing research and making a meaningful impact together. AIDS Healthcare Foundation (AHF) AHF Africa IAS - the International AIDS Society